Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou've started Wegovy, or you're about to. The pen is in the fridge, the clinic appointment is done, and now the real question is: how do you use this treatment well? Semaglutide works by activating GLP-1 receptors to reduce appetite and slow gastric emptying, but the clinical evidence is clear that the people who see the strongest results pair the medicine with consistent habits from the first week. Wegovy is a prescription-only medicine — a prescriber assesses your suitability before it's issued — and these practices apply once you're under clinical supervision. The NHS patient guide to semaglutide is worth bookmarking alongside this page.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it's Sunday evening, you've just remembered your Wegovy pen is due, and you're not sure whether you took it yesterday or the day before. That moment of uncertainty is exactly what a fixed injection day prevents. Semaglutide is the active ingredient in Wegovy, and it maintains a steady concentration in the body across the week, but that stability depends on doses arriving at roughly the same 24-hour window each time. Missing or doubling up disrupts the rhythm your prescriber has built into your titration plan.
Choosing a day that suits your actual life (not the day you happened to start) is worth thinking about early. Picking the right day to start Wegovy covers this in more detail, but the short version is: pick a day when you're unlikely to be travelling, hosting dinner, or in a situation where a bout of nausea would be particularly inconvenient. Many people settle on a Thursday or Friday so any first-few-days queasiness clears before the working week. Once you've chosen, a 30-second calendar repeat on your phone is enough. That's the whole habit.
If you do miss a window, your Patient Information Leaflet sets out exactly what to do, the guidance varies depending on how much time has passed, and your prescriber is the right person to ask if you're unsure. Never take two doses to compensate.
One of the things patients tell us they wish they'd heard earlier is that a reduced appetite can quietly lead to under-eating protein. When overall food intake drops, the body's need for adequate protein doesn't drop with it, if anything it becomes more pressing, because preserving muscle mass during weight loss depends on it. Aim to make protein the first consideration when you're planning a meal, not an afterthought once the plate is assembled.
Hydration follows the same logic. Nausea, a common early side effect, tends to put people off fluids as well as food. Staying well hydrated matters both for general wellbeing and because dehydration can amplify the GI discomfort that semaglutide sometimes causes in early weeks. Small, frequent sips work better than trying to drink a large glass when you already feel uncomfortable.
Portion sizes are also worth approaching differently on this treatment. Because gastric emptying slows, eating past the point of early fullness is more likely to cause reflux or bloating than it would have before. The NHS England guidance on weight-management injections specifically notes that a reduced-calorie diet alongside the medicine improves outcomes, the medicine reduces hunger, but it works alongside food choices rather than instead of them. High-fat meals in particular can worsen nausea in the early weeks.
Most people on Wegovy experience some degree of nausea, and many also notice constipation or, less commonly, loose stools, especially after starting a new dose. These are well-documented effects of GLP-1 medicines and are generally mild to moderate. They tend to ease as your body adjusts, usually within days to two weeks of a dose change.
The practical moves that help: eating smaller meals more often rather than two or three large ones; avoiding lying down immediately after eating; keeping rich or very fatty foods to a minimum during titration. None of these require a dramatic overhaul, they're small adjustments that add up.
Knowing when to seek help promptly is a different matter. Severe stomach pain that radiates to the back, with or without vomiting, needs same-day medical attention, this is the symptom pattern associated with pancreatitis, which the MHRA flagged in its January 2026 Drug Safety Update for GLP-1 medicines. Gallbladder symptoms (sharp pain in the upper right abdomen, particularly after eating), signs of a serious allergic reaction, or any symptoms that feel out of proportion to what you'd expect should all prompt you to contact a clinician rather than wait. You can also report unexpected side effects directly via the MHRA's Yellow Card scheme.
Wegovy works over months, not weeks. The titration schedule exists for a reason: each dose step gives your system time to adjust before the next increase, and trying to rush that process (or skipping a step because you feel ready) is something to discuss with your prescriber rather than decide alone. If you're weighing up the best way to start Wegovy, understanding how the titration plan is designed to work is one of the most useful things you can do before your first dose.
Repeat prescriptions at nume involve a clinical re-review before every order, which means your prescriber is checking that the treatment is still appropriate and that any side effects are within expected range. That's not bureaucracy; it's a genuine safety check. If you have questions between doses, our support team is available seven days a week.
Thinking about what happens at the end of treatment is also best practice, not premature. Stopping Wegovy without a plan is associated with weight regain, and your prescriber can help you think through a structured approach before you reach that point. Similarly, if you're still researching whether this is the right treatment for you, understanding how Wegovy is priced and the best way to get Wegovy through a regulated provider can help you compare options with confidence. And when you're ready to start a free consultation, you can check your eligibility here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.